Ceres Power Holdings PLC Logo

Ceres Power Holdings PLC

CWR | IL

Overview

Corporate Details

ISIN(s):
GB00BG5KQW09 (+1 more)
LEI:
213800N7AAHSXQUOA733
Country:
United Kingdom
Address:
VIKING HOUSE, RH13 5PX HORSHAM
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Ceres Power Holdings PLC is a leading developer of clean energy technology, specializing in solid oxide fuel cells (SOFC) for power generation and solid oxide electrolysers (SOEC) for green hydrogen production. The company operates an asset-light, intellectual property-centric business model, licensing its world-leading technology to a global ecosystem of manufacturing partners, including major corporations like Doosan, Delta Electronics, and Shell. Grounded in over two decades of R&D and protected by a broad patent portfolio, Ceres' scalable technology offers an efficient and cost-effective pathway to decarbonize complex energy systems across multiple industries.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Ceres Power Holdings PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-31 11:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 10.0 KB
2025-07-28 08:00
Environmental & Social Information
Doosan Fuel Cell and Ceres joint announcement
English 15.0 KB
2025-07-10 17:05
Major Shareholding Notification
Holding(s) in Company
English 29.4 KB
2025-07-09 18:25
Major Shareholding Notification
Holding(s) in Company
English 28.9 KB
2025-07-07 11:00
Share Issue/Capital Change
Block listing Interim Review
English 17.9 KB
2025-06-27 12:00
Remuneration Information
Grant of Long Term Incentive Plan (“LTIP”) Awards
English 34.3 KB
2025-05-30 11:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 9.6 KB
2025-05-16 12:58
Post-Annual General Meeting Information
Special Resolutions passed at the 2025 AGM
English 158.3 KB
2025-05-15 16:15
Post-Annual General Meeting Information
Result of AGM
English 39.3 KB
2025-03-31 08:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 8.2 KB
2025-03-11 08:28
Report Publication Announcement
Notice of results and revised trading update
English 11.5 KB
2025-02-28 08:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 8.2 KB
2025-02-20 12:45
Board/Management Information
Directorate Change
English 8.2 KB
2025-02-20 08:00
Business and Financial Review
Statement regarding Robert Bosch GmbH
English 11.3 KB
2025-01-31 08:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 8.0 KB

Automate Your Workflow. Get a real-time feed of all Ceres Power Holdings PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Ceres Power Holdings PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN